Concepedia

Steven C. L. Ho

SC

Statistics

Publications

16

Citations

869

H-Index

15

Active since

2007

Affiliations

Agency for Science, Technology and Research(Current)

Bioprocessing Technology Institute

National University of Singapore

Nanyang Technological University

University of Edinburgh

Steven C. L. Ho is an author at Agency for Science, Technology and Research specializing in medicine, cell biology, and immunology.

ORCID

Top concepts

Publications per year

2007–2017

16

Publications

16

IRES-mediated Tricistronic vectors for enhancing generation of high monoclonal antibody expressing CHO cell lines

Steven C. L. Ho, Muriel Bardor, Huatao Feng et al. · Journal of Biotechnology · 2011 · 147 citations

, , +8

Optimization of Heavy Chain and Light Chain Signal Peptides for High Level Expression of Therapeutic Antibodies in CHO Cells

Ryan Haryadi, Steven C. L. Ho, Yee Jiun Kok et al. · PLoS ONE · 2015 · 124 citations · Full text

, , +22

Changes in breast cancer transcriptional profiles after treatment with the aromatase inhibitor, letrozole

William R. Miller, Alexey A. Larionov, Lorna Renshaw et al. · Pharmacogenetics and Genomics · 2007 · 106 citations

Control of IgG LC:HC ratio in stably transfected CHO cells and study of the impact on expression, aggregation, glycosylation and conformational stability

Steven C. L. Ho, Esther Y. C. Koh, Miranda van Beers et al. · Journal of Biotechnology · 2013 · 97 citations

, , +12

Comparison of Internal Ribosome Entry Site (IRES) and Furin-2A (F2A) for Monoclonal Antibody Expression Level and Quality in CHO Cells

Steven C. L. Ho, Muriel Bardor, Bin Li et al. · PLoS ONE · 2013 · 70 citations · Full text

, , +18

1–5 of 16